Centralization of Strain R&D

Cannabis research and strain development have traditionally been concentrated in the hands of a few well-funded labs and corporations.

These entities invest heavily in genetics, breeding techniques and intellectual property protections. While they benefit from patents, licensing fees and downstream revenues, the broader community growers, dispensaries and consumers are excluded from both participation and ownership.

This centralization limits innovation and creates barriers for smaller breeders who lack the resources to compete.